Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information
09 août 2017 16h39 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Announces Co-Development of Four Additional Products with SunGen Pharma
28 juil. 2017 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., July 28, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Announces New Development and License Agreement with SunGen Pharma LLC
12 juil. 2017 08h31 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., July 12, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
30 mai 2017 08h42 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 30, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today reported positive topline results from pivotal bioequivalence studies...
'Patent Cliff' for Blockbuster Drugs Energizing Global Generics Market Market Predicted to Add $181 billion by 2021
08 mars 2017 08h00 HE
|
BCC Research
Wellesley, Mass, March 08, 2017 (GLOBE NEWSWIRE) -- New proprietary research by BCC Research predicts the global generics market to reach $533 billion from 2016-2021, driven by pharmaceutical...
Earth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory Board
28 févr. 2017 08h00 HE
|
Earth Science Tech, Inc.
Hollywood, Feb. 28, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid...
Elite Pharmaceuticals, Inc. Reports Results for Third Quarter of Fiscal Year 2017
09 févr. 2017 16h34 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended December 31, 2016, the third quarter...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017
07 févr. 2017 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Announces Development and License Agreement with SunGen Pharma LLC
29 août 2016 08h00 HE
|
Elite Pharmaceuticals, Inc.; SunGen Pharma, LLC
NORTHVALE, N.J., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...
Elite Pharmaceuticals files ANDA to Market Generic Percocet
10 août 2016 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced that it has filed an Abbreviated New Drug Application (ANDA)...